← All stocks

HALOZYME THERAPEUTICS, INC.

HALO Scheduled selling only

CIK 0001159036 #857 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$12.71M

$0.00 on a plan · $12.71M straight out of an exercise

Sold at will

$0.00

0 of 18 sales

Net

−$12.71M

$0.00 against sales at will

By person

14 insiders · 18 transactions

82.5×

Helen I. Torley holds 82.5 times base salary in stock. $82.57M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Helen I. Torley last reported holding, valued at $107.55, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Torley Helen

PRESIDENT AND CEO

—

$12.71M (18) scheduled

−$12.71M

767,780

0.6765%

$82.57M

+13.5%

MATSUI CONNIE

Director

—

183,035

0.1613%

$19.69M

−5.4%

LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

—

173,756

0.1531%

$18.69M

0.0%

Posard Matthew L.

Director

—

77,835

0.0686%

$8.37M

+11.4%

Snyder Mark Howard

SVP, CHIEF LEGAL OFFICER

—

49,929

0.0440%

$5.37M

+327.5%

Connaughton Bernadette

Director

—

40,418

0.0356%

$4.35M

−13.6%

LaBrosse Nicole

SVP, CHIEF FINANCIAL OFFICER

—

38,494

0.0339%

$4.14M

+148.7%

Henderson Jeffrey William

Director

—

36,572

0.0322%

$3.93M

−31.8%

Miyashita Akiko Moni

Director

—

24,937

0.0220%

$2.68M

+20.1%

DUNCAN BARBARA GAYLE

Director

—

23,715

0.0209%

$2.55M

+50.5%

Krishnan Mahesh

Director

—

14,462

0.0127%

$1.56M

+122.5%

Caudill Cortney

SVP, CHIEF OPERATING OFFICER

—

7,055

0.0062%

$758.75K

−8.1%

Lang James Paul

Director

—

4,685

0.0041%

$503.86K

—

RAMSAY DAVID A

EVP, PRESIDENT, DRUG DELIVERY

—

4,592

0.0040%

$493.86K

—

HALOZYME THERAPEUTICS, INC.

By person

Individual transactions

What was left out